این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
چهارشنبه 22 بهمن 1404
Medical Journal of Islamic Republic of Iran
، جلد ۳۰، شماره ۱، صفحات ۵۰۴-۵۰۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Outcomes of assisted reproduction treatment after dopamine agonist -cabergoline- for prevention of ovarian hyper stimulation syndrome
چکیده انگلیسی مقاله
Background: Release of vascular endothelial growth factor (VEGF) by ovaries in response to HCG administration is one of the main mechanisms of ovarian hyper stimulation syndrome. Since Dopamine/dopamine receptor2 (Dp-r2) pathway activity -mediated by VEGF/ Vascular endothelial growth factor receptor 2 (VEGFR-2) signaling-, is associated with angiogenic events, dopamine agonists were used for the management of severe forms of OHSS. In order to assess the effects of Cabergoline on angiogenesis in the human endometrium, and subsequently its impacts on the implantation rate this study was conducted. Methods: This historical cohort study was conducted based on existing data of 115 patients (20-40 years) whom underwent assisted reproductive treatment (ART) and with a high probability for developing OHSS between March 2007 and September 2008. Forty five cases received Cabergoline were compared to 70 control subjects. The statistical methods used were: Unpaired t-test for continuous variables and the chi-square test (or Fisher's exact test if required) for categorical variables. Results: None of the patients (treatment or control group) developed OHSS. The etiologies of infertility and administration of GnRH agonist or antagonist protocols were similar in two groups (p>0.2). Number of transferred embryos and zygote intra-fallopian transfer (ZIFT) did not differ between the two groups (p≥0.06). Implantation rate in treatment (3.1%) and control (6.6%) subjects was similar (p=0.4). No significant difference was observed in fertilization rate, chemical, clinical and ongoing pregnancies between the two groups (p>0.5). Conclusion: Cabergoline can be safely administered in ART protocols to prevent OHSS, without compromising ART outcomes.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
شهره موحدی | shohreh movahedi
fellowship in infertility, department of infertility of shariati hospital, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
لیلی صفدریان | leili safdarian
fellowship in infertility, department of infertility, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
مرضیه agahoseini | marzieh agahoseini
department of infertility of shariati hospital, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
اشرف آل یاسین | ashraf aleyasin
department of infertility of shariati hospital, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
سپیده خداوردی | sepideh khodaverdi
endometriosis research center, iran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
سارا اسدالله | sara asadollah
endometriosis research center, iran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی ایران (Iran university of medical sciences)
علی کرد والش آباد | ali kord valeshabad
department of ophthalmology and visual sciences, university of illinois at chicago, chicago, il, usa.
پروین فلاحی | parvin fallahi
department of infertility of shariati hospital, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
زهرا رضاییان | zahra rezaeeian
department of infertility of shariati hospital, tehran university of medical sciences, tehran, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی تهران (Tehran university of medical sciences)
نشانی اینترنتی
http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-1003&slc_lang=en&sid=en
فایل مقاله
اشکال در دسترسی به فایل - ./files/site1/rds_journals/18/article-18-568035.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
Gynecology & Obstetrics
نوع مقاله منتشر شده
Original Research
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات